ORGANIGRAM HOLDINGS INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.59 CAD | -4.43% |
|
+4.44% | +50.58% |
| May. 14 | Toronto Stocks Edge Down; Hudbay Minerals Rises on 1Q Earnings Beat | DJ |
| May. 14 | Transcript : Organigram Holdings Inc., Q2 2024 Earnings Call, May 14, 2024 |
Valuation
| Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 710.6 | 274.3 | 875.5 | 382.7 | 144.9 | 280.1 | - | - |
| Enterprise Value (EV) 1 | 712.3 | 314.8 | 692.2 | 284.4 | 144.9 | 280.1 | 280.1 | 280.1 |
| P/E ratio | -66.9 x | -1.79 x | -5.73 x | -26.5 x | -0.59 x | -4.52 x | -18.1 x | -45.2 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 8.84 x | 3.16 x | 11.1 x | 2.62 x | 0.9 x | 1.77 x | 1.51 x | 1.25 x |
| EV / Revenue | 8.84 x | 3.16 x | 11.1 x | 2.62 x | 0.9 x | 1.77 x | 1.51 x | 1.25 x |
| EV / EBITDA | 35.7 x | -11.6 x | -29.2 x | 110 x | 24.4 x | 84.7 x | 22.5 x | 11.6 x |
| EV / FCF | -4.94 x | -2.24 x | -21.7 x | -4.5 x | -2.13 x | -11.2 x | -12.7 x | -10.4 x |
| FCF Yield | -20.2% | -44.6% | -4.61% | -22.2% | -46.9% | -8.92% | -7.85% | -9.64% |
| Price to Book | 1.96 x | 0.92 x | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 39,045 | 48,627 | 74,954 | 78,427 | 80,520 | 103,370 | - | - |
| Reference price 2 | 18.20 | 5.640 | 11.68 | 4.880 | 1.800 | 2.710 | 2.710 | 2.710 |
| Announcement Date | 11/25/19 | 11/30/20 | 11/23/21 | 11/29/22 | 12/19/23 | - | - | - |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 80.41 | 86.8 | 79.16 | 145.8 | 161.6 | 158.6 | 185.8 | 224.8 |
| EBITDA 1 | 19.9 | -23.63 | -30.03 | 3.484 | 5.951 | 3.309 | 12.46 | 24.23 |
| EBIT 1 | 5.487 | -67.46 | -76.99 | -34.11 | -275.8 | -50 | -21.67 | -7.15 |
| Operating Margin | 6.82% | -77.72% | -97.26% | -23.39% | -170.6% | -31.53% | -11.66% | -3.18% |
| Earnings before Tax (EBT) 1 | -5.875 | -146.6 | -130.7 | -14.37 | -252.4 | -66.16 | -22.22 | 13.7 |
| Net income 1 | -9.542 | -136.2 | -130.7 | -14.28 | -248.6 | -57.38 | -19.24 | -9 |
| Net margin | -11.87% | -156.87% | -165.11% | -9.8% | -153.8% | -36.19% | -10.36% | -4% |
| EPS 2 | -0.2720 | -3.156 | -2.040 | -0.1840 | -3.058 | -0.6000 | -0.1500 | -0.0600 |
| Free Cash Flow 1 | -143.8 | -122.3 | -40.38 | -84.96 | -67.92 | -25 | -22 | -27 |
| FCF margin | -178.88% | -140.96% | -51.01% | -58.27% | -42.02% | -15.77% | -11.84% | -12.01% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 11/25/19 | 11/30/20 | 11/23/21 | 11/29/22 | 12/19/23 | - | - | - |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: September | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 30.38 | 31.84 | 38.12 | 45.48 | 46.04 | 36.46 | 37.63 | 39.95 | 43.28 | 44.1 | 43.8 | 46.87 |
| EBITDA 1 | -1.887 | 1.556 | 0.583 | 3.232 | -2.36 | 0.135 | -1.045 | 1.748 | 3.695 | 2.5 | 2.35 | 3.8 |
| EBIT 1 | -11.88 | -9.138 | -10.9 | -2.187 | - | -15.93 | -14.98 | -12.02 | -11.07 | - | - | - |
| Operating Margin | -39.1% | -28.7% | -28.61% | -4.81% | - | -43.69% | -39.8% | -30.08% | -25.58% | - | - | - |
| Earnings before Tax (EBT) 1 | -1.305 | -4.144 | -2.479 | -6.443 | -35.27 | -15.75 | -27.1 | -12.36 | -10.94 | - | - | - |
| Net income 1 | -1.305 | -4.047 | -2.787 | -6.144 | -32.99 | -15.75 | -27.08 | -12.36 | -10.94 | - | - | - |
| Net margin | -4.3% | -12.71% | -7.31% | -13.51% | -71.66% | -43.2% | -71.95% | -30.95% | -25.27% | - | - | - |
| EPS 2 | -0.0160 | -0.0520 | -0.0360 | -0.0800 | -0.1050 | -0.1940 | -0.2970 | -0.0633 | -0.0400 | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 1/11/22 | 4/12/22 | 7/14/22 | 11/29/22 | 12/19/23 | 2/13/24 | 5/14/24 | - | - | - | - | - |
1CAD in Million2CAD
Estimates
Balance Sheet Analysis
| Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | 1.64 | 40.5 | - | - | - | - | - | - |
| Net Cash position | - | - | 183 | 98.4 | - | - | - | - |
| Leverage (Debt/EBITDA) | 0.0825 x | -1.715 x | - | - | - | - | - | - |
| Free Cash Flow 1 | -144 | -122 | -40.4 | -85 | -67.9 | -25 | -22 | -27 |
| ROE (net income / shareholders' equity) | -3.73% | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share | 9.280 | 6.160 | - | - | - | - | - | - |
| Cash Flow per Share | 0.5800 | -1.720 | - | - | - | - | - | - |
| Capex 1 | 109 | 77.2 | 11.8 | 48.7 | 29.1 | 4 | 7 | 4 |
| Capex / Sales | 135.26% | 88.97% | 14.89% | 33.43% | 18.03% | 2.52% | 3.77% | 1.78% |
| Announcement Date | 11/25/19 | 11/30/20 | 11/23/21 | 11/29/22 | 12/19/23 | - | - | - |
1CAD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
2.71
CAD
Average target price
3.629
CAD
Spread / Average Target
+33.90%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +50.58% | 206M | |
| -.--% | 339M | |
| +43.21% | 299M | |
| +23.71% | 279M | |
| +161.28% | 154M | |
| +46.63% | 132M | |
| -42.86% | 122M | |
| -42.66% | 119M | |
| +7.69% | 118M | |
| +100.00% | 60.26M |
- Stock Market
- Equities
- OGI Stock
- Financials Organigram Holdings Inc.
